Parallels in the pathogenesis of SARS-CoV-2 and : a synergistic or antagonistic alliance?
作者信息
Tapela Kesego, Ochieng' Olwal Charles, Quaye Osbourne
机构信息
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
Department of Biochemistry, Cell & Molecular Biology, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana.
出版信息
Future Microbiol. 2020 Dec;15:1691-1695. doi: 10.2217/fmb-2020-0179. Epub 2021 Jan 6.
Abstract
摘要
相似文献
1
Parallels in the pathogenesis of SARS-CoV-2 and : a synergistic or antagonistic alliance?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病机制中的相似之处以及：协同还是拮抗联盟？
需注意，原文中“and :”表述不太完整准确，可能影响理解。
Future Microbiol. 2020 Dec;15:1691-1695. doi: 10.2217/fmb-2020-0179. Epub 2021 Jan 6.
2
Pathogenesis of SARS-CoV-2 and Coinfection.SARS-CoV-2 的发病机制及合并感染。
Front Immunol. 2022 Jun 16;13:909011. doi: 10.3389/fimmu.2022.909011. eCollection 2022.
3
Pathology of TB/COVID-19 Co-Infection: The phantom menace.结核/COVID-19 合并感染的病理学：幽灵般的威胁。
Tuberculosis (Edinb). 2021 Jan;126:102020. doi: 10.1016/j.tube.2020.102020. Epub 2020 Nov 17.
4
Protective interplay: diminishes SARS-CoV-2 severity through innate immune priming.保护性相互作用：通过先天免疫启动降低 SARS-CoV-2 严重程度。
Front Immunol. 2024 Jun 20;15:1424374. doi: 10.3389/fimmu.2024.1424374. eCollection 2024.
5
Molecular and Cellular Mechanisms of and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection.新型冠状病毒和严重急性呼吸综合征冠状病毒 2 感染的分子和细胞机制-发病机制的意外相似之处及合并感染的预期后果。
Int J Mol Sci. 2022 Feb 17;23(4):2235. doi: 10.3390/ijms23042235.
6
Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.冠状病毒增加宿主细胞表面受体血管紧张素转化酶 2 的表达可能有助于 2019-nCoV（或 SARS-CoV-2）感染。
J Med Virol. 2020 Nov;92(11):2693-2701. doi: 10.1002/jmv.26139. Epub 2020 Jul 2.
7
Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 Cytokine Storm?肠道微生物群的扰动是否可能加剧 COVID-19 细胞因子风暴的严重程度？
Front Immunol. 2021 Jan 25;11:607734. doi: 10.3389/fimmu.2020.607734. eCollection 2020.
8
Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.SARS-CoV-2 包膜蛋白与分枝杆菌属抗原之间具有很强的同源性，这使得分枝杆菌属感染的快速诊断成为可能，并且卡介苗疫苗可能通过提供针对 SARS-CoV-2 的特异性免疫力。
Ann Diagn Pathol. 2020 Oct;48:151600. doi: 10.1016/j.anndiagpath.2020.151600. Epub 2020 Aug 13.
9
Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.结核分枝杆菌既往流行与 COVID-19 死亡率和发病率的关系。
PLoS One. 2021 Jun 18;16(6):e0253169. doi: 10.1371/journal.pone.0253169. eCollection 2021.
10
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.COVID-19 合并合并感染患者的影响：系统评价和荟萃分析。
J Med Virol. 2021 Apr;93(4):2385-2395. doi: 10.1002/jmv.26740. Epub 2020 Dec 29.
引用本文的文献
1
Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study.德黑兰一家三级护理中心新诊断结核病患者中 COVID-19 既往感染：一项病例对照研究。
Immun Inflamm Dis. 2024 May;12(5):e1275. doi: 10.1002/iid3.1275.
2
Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning.通过生物信息学分析和机器学习识别结核病和 SARS-CoV-2 感染之间的相互作用。
Biochem Genet. 2024 Aug;62(4):2606-2630. doi: 10.1007/s10528-023-10563-x. Epub 2023 Nov 22.
3
Lipid Mediators and Cytokines/Chemokines Display Differential Profiles in Severe versus Mild/Moderate COVID-19 Patients.严重与轻度/中度 COVID-19 患者的脂质介质和细胞因子/趋化因子呈现不同特征。
Int J Mol Sci. 2023 Aug 22;24(17):13054. doi: 10.3390/ijms241713054.
4
The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.在一家地区医院因 COVID-19 住院的一系列 HIV 感染者的临床和流行病学特征。
BMC Infect Dis. 2023 Feb 28;23(1):123. doi: 10.1186/s12879-023-08004-6.
5
Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis.SARS-CoV-2 再感染对卡介苗免疫具有有害影响，并促进结核分枝杆菌的传播。
Microbiol Spectr. 2022 Oct 26;10(5):e0307522. doi: 10.1128/spectrum.03075-22. Epub 2022 Oct 6.
6
Review of Pediatric Tuberculosis in the Aftermath of COVID-19.新冠疫情后儿童结核病综述
Clin Pract. 2022 Sep 11;12(5):738-754. doi: 10.3390/clinpract12050077.
7
Disseminated Histoplasmosis, Pulmonary Tuberculosis, and Cytomegalovirus Disease in a Renal Transplant Recipient after Infection with SARS-CoV-2.一名感染新型冠状病毒后接受肾移植的患者并发播散性组织胞浆菌病、肺结核和巨细胞病毒病
Case Rep Transplant. 2022 Aug 28;2022:8042168. doi: 10.1155/2022/8042168. eCollection 2022.
8
Pathogenesis of SARS-CoV-2 and Coinfection.SARS-CoV-2 的发病机制及合并感染。
Front Immunol. 2022 Jun 16;13:909011. doi: 10.3389/fimmu.2022.909011. eCollection 2022.
9
Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis.新型冠状病毒血清阳性对潜伏性结核抗原特异性细胞因子和趋化因子反应的影响。
Cytokine. 2022 Feb;150:155785. doi: 10.1016/j.cyto.2021.155785. Epub 2021 Dec 14.
10
Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?作为疾病结局调节因子的合并感染：小角色还是主要角色？
Front Microbiol. 2021 Jul 6;12:664386. doi: 10.3389/fmicb.2021.664386. eCollection 2021.
本文引用的文献
1
Correlation between immunity from BCG and the morbidity and mortality of COVID-19.卡介苗诱导的免疫力与新冠病毒病的发病率和死亡率之间的相关性
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:17. doi: 10.1186/s40794-020-00117-z. eCollection 2020.
2
BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study.BCG 疫苗接种与 173 个国家 COVID-19 死亡率的关系：一项生态学研究。
Int J Environ Res Public Health. 2020 Aug 3;17(15):5589. doi: 10.3390/ijerph17155589.
3
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?SARS-CoV-2 感染中的肺巨噬细胞：是敌是友？
Front Immunol. 2020 Jun 5;11:1312. doi: 10.3389/fimmu.2020.01312. eCollection 2020.
4
Severe COVID-19: A Review of Recent Progress With a Look Toward the Future.严重的 COVID-19：近期进展回顾及未来展望。
Front Public Health. 2020 May 13;8:189. doi: 10.3389/fpubh.2020.00189. eCollection 2020.
5
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.描述感染 HIV 的个体中的 COVID-19：单中心前瞻性队列研究。
Lancet HIV. 2020 Aug;7(8):e554-e564. doi: 10.1016/S2352-3018(20)30164-8. Epub 2020 May 28.
6
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.COVID-19 中的细胞因子风暴：趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
7
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.干扰素 beta-1b、洛匹那韦利托那韦和利巴韦林三联治疗住院 COVID-19 患者：一项开放标签、随机、2 期试验。
Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.
8
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫：能提供针对 COVID-19 的保护吗？
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
9
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症：单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
10
Cell entry mechanisms of SARS-CoV-2.SARS-CoV-2 的细胞进入机制。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6.
Zotero 插件